PGLP-1, a novel long-acting dual-function GLP-1 analog, ameliorates streptozotocin-induced hyperglycemia and inhibits body weight loss.
Gao H, Zhao Q, Song Z, Yang Z, Wu Y, Tang S, Alahdal M, Zhang Y, Jin L.
Gao H, et al. Among authors: song z.
FASEB J. 2017 Aug;31(8):3527-3539. doi: 10.1096/fj.201700002R. Epub 2017 May 1.
FASEB J. 2017.
PMID: 28461341
Taken together, these data indicated that PGLP-1, as a dual-function peptide, improved glycemic control and inhibited body weight loss, suggesting it could be useful for type 1 diabetes mellitus patients as an adjunctive therapy to insulin.-Gao, H., Zhao, Q., Song, Z …
Taken together, these data indicated that PGLP-1, as a dual-function peptide, improved glycemic control and inhibited body weight loss, sugg …